Short answer
Chemours Co (CC) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $1.4B (up 1.0% year over year) with net income of −$29M.
Q1 2026 key financials · XBRL
- Revenue
- $1.4B
- +1.0% YoY
- Net income
- −$29M
- −625.0% YoY
- Gross margin
- 15.4%
- EPS (diluted)
- −$0.19
- −533.3% YoY
Source: XBRL data from the Chemours Co (CC) Q1 2026 10-Q on SEC EDGAR. USD.
Chemours Co Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly updated PFAS regulatory risk: EPA began rulemaking to rescind index-PFAS MCLs while retaining PFOA/PFOS MCLs
- Most material environmental risk: Fayetteville Consent Order remediation costs may exceed recorded reserves
- EU compliance risk: PFAS restriction evaluation continues, with earliest restrictions potentially effective in 2027
- Product-market risk: EU TFA classification proposal could impose binding reproductive-toxicity and PMT/vPvM requirements
- Financial risk: Environmental liabilities and litigation accruals could increase materially under new drinking-water standards
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Chemours Co quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.